137 related articles for article (PubMed ID: 33583686)
1. Validation of the ENDPAC model: Identifying new-onset diabetics at risk of pancreatic cancer.
Khan S; Safarudin RF; Kupec JT
Pancreatology; 2021 Apr; 21(3):550-555. PubMed ID: 33583686
[TBL] [Abstract][Full Text] [Related]
2. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.
Sharma A; Kandlakunta H; Nagpal SJS; Feng Z; Hoos W; Petersen GM; Chari ST
Gastroenterology; 2018 Sep; 155(3):730-739.e3. PubMed ID: 29775599
[TBL] [Abstract][Full Text] [Related]
3. Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.
Chari ST; Maitra A; Matrisian LM; Shrader EE; Wu BU; Kambadakone A; Zhao YQ; Kenner B; Rinaudo JAS; Srivastava S; Huang Y; Feng Z;
Contemp Clin Trials; 2022 Feb; 113():106659. PubMed ID: 34954100
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Models Screen New-Onset Diabetics at Low Risk of Early-Onset Pancreatic Cancer.
Khan S; Al Heraki S; Kupec JT
Pancreas; 2021 Oct; 50(9):1326-1330. PubMed ID: 34860819
[TBL] [Abstract][Full Text] [Related]
5. Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol.
Claridge H; Price CA; Ali R; Cooke EA; de Lusignan S; Harvey-Sullivan A; Hodges C; Khalaf N; O'Callaghan D; Stunt A; Thomas SA; Thomson J; Lemanska A
BMJ Open; 2024 Jan; 14(1):e079863. PubMed ID: 38262635
[TBL] [Abstract][Full Text] [Related]
6. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.
Boursi B; Finkelman B; Giantonio BJ; Haynes K; Rustgi AK; Rhim AD; Mamtani R; Yang YX
Gastroenterology; 2017 Mar; 152(4):840-850.e3. PubMed ID: 27923728
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model in a Diverse and Integrated Healthcare Setting.
Chen W; Butler RK; Lustigova E; Chari ST; Wu BU
Dig Dis Sci; 2021 Jan; 66(1):78-87. PubMed ID: 32112260
[TBL] [Abstract][Full Text] [Related]
8. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening.
Zhang Z; Qin W; Sun Y
Pathol Res Pract; 2018 Dec; 214(12):1923-1928. PubMed ID: 30477640
[TBL] [Abstract][Full Text] [Related]
9. Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes.
Klatte DCF; Clift KE; Mantia SK; Millares L; Hoogenboom SAM; Presutti RJ; Wallace MB
Prev Med Rep; 2023 Feb; 31():102110. PubMed ID: 36820377
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus in pancreatic cancer patients in the Czech Republic: sex differences.
Trna J; Dítĕ P; Adamcová A; Crawford BJ; Hermanová M
Exp Diabetes Res; 2012; 2012():414893. PubMed ID: 22792091
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of CA 19-9 for pancreatic cancer screening in patients with new-onset diabetes.
Choe JW; Kim HJ; Kim JS; Cha J; Joo MK; Lee BJ; Park JJ; Bak YT
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):263-268. PubMed ID: 29752133
[TBL] [Abstract][Full Text] [Related]
12. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a review.
Khadka R; Tian W; Hao X; Koirala R
Int J Surg; 2018 Apr; 52():342-346. PubMed ID: 29535016
[TBL] [Abstract][Full Text] [Related]
13. Diabetic Ketoacidosis as the Initial Presenting Symptom of Pancreatic Adenocarcinoma: A Discussion about Screening Utilizing ENDPAC Scoring Coupled with CT Scans and Endoscopic Ultrasound.
Menakuru SR; Priscu A; Dhillon VS; Salih A
Case Rep Oncol; 2022; 15(3):942-949. PubMed ID: 36636678
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.
Chari ST; Leibson CL; Rabe KG; Timmons LJ; Ransom J; de Andrade M; Petersen GM
Gastroenterology; 2008 Jan; 134(1):95-101. PubMed ID: 18061176
[TBL] [Abstract][Full Text] [Related]
15. New-onset diabetes patients need pancreatic cancer screening?
Lee JH; Kim SA; Park HY; Lee KH; Lee KT; Lee JK; Bae JC; Kim KW
J Clin Gastroenterol; 2012 Aug; 46(7):e58-61. PubMed ID: 22138846
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable From Conventional Diabetes.
Yoon BH; Ang SM; Alabd A; Furlong K; Yeo CJ; Lavu H; Winter JM
J Surg Res; 2021 May; 261():215-225. PubMed ID: 33453685
[TBL] [Abstract][Full Text] [Related]
17. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.
Fahrmann JF; Schmidt CM; Mao X; Irajizad E; Loftus M; Zhang J; Patel N; Vykoukal J; Dennison JB; Long JP; Do KA; Zhang J; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger J; Yip-Schneider MT; Maitra A; Wolpin BM; Hanash S
Gastroenterology; 2021 Mar; 160(4):1373-1383.e6. PubMed ID: 33333055
[TBL] [Abstract][Full Text] [Related]
18. The seemingly innocuous presentation of metastatic pancreatic tail cancer: a case report.
Rahman M; Washington L
J Med Case Rep; 2019 Jun; 13(1):178. PubMed ID: 31182138
[TBL] [Abstract][Full Text] [Related]
19. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer.
Pannala R; Basu A; Petersen GM; Chari ST
Lancet Oncol; 2009 Jan; 10(1):88-95. PubMed ID: 19111249
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
